Lidocaine ophthalmic Pregnancy and Breastfeeding Warnings
Lidocaine ophthalmic is also known as: Akten
Lidocaine ophthalmic Pregnancy Warnings
This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.
US FDA pregnancy category: B
Animal studies have failed to reveal evidence of fetal harm when given subcutaneously at doses up to 50 mg/kg. There are no controlled data in human pregnancy.
US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Lidocaine ophthalmic Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Yes
Comments:
-Systemic exposure is not expected.
-The effects in the nursing infant are unknown.
References for pregnancy information
- "Product Information. Akten (lidocaine ophthalmic)." Akorn Inc, Buffalo Grove, IL.
References for breastfeeding information
- United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
- "Product Information. Akten (lidocaine ophthalmic)." Akorn Inc, Buffalo Grove, IL.
See Also...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
